Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDerwent London Regulatory News (DLN)

Share Price Information for Derwent London (DLN)

Share Price is delayed by 15 minutes
Get Live Data
1,762.00    -3.00 (-0.17%)
Bid:
1,766.00
Ask:
1,769.00
Spread: 3.00 (0.17%)
Market Cap: £1.98b
DLN Live PriceLast checked at - London Stock Exchange

Intraday Derwent London Share Chart

Refinancing

1 Oct 2013 09:58

RNS Number : 3878P
Derwent London PLC
01 October 2013
 



1 October 2013

 

Derwent London signs new £550m five year unsecured bank facility

 

Derwent London ("Derwent London plc"/ "the Group") announces today that it has signed a new £550m unsecured five year revolving credit facility.

 

The new facility is being provided by the Group's principal relationship banks, HSBC, RBS, Barclays and Lloyds, with HSBC as agent. It replaces £650m of secured bank facilities expiring between April 2014 and January 2017, as was indicated in the Group's interim results announced in August and follows on from the Group's issue in July of £150m of convertible bonds due in July 2019.

 

The margin payable under the new facility is 160 basis points over LIBOR for net asset gearing levels of up to 50%. The margin increases at higher levels of gearing with a maximum permitted level of 160%. The current level of Group net asset gearing is 40.4% based on June 2013 property values.

 

Damian Wisniewski, Finance Director of Derwent London, commented:

 

"Our new unsecured bank facility brings greater operational flexibility in relation to individual properties and the release of security on the facilities repaid provides the Group with a pool of unencumbered assets of over £1.8bn. We are pleased to have put these new arrangements in place at competitive pricing."

 

-ends-

 

 

For further information please contact:

 

Derwent London 020 7659 3000

 

Damian Wisniewski, Finance Director

 

Louise Rich, Head of Investor Relations

 

 

Brunswick Group 020 7404 5959

 

Elizabeth Adams

 

Sheena Shah

 

 

 

Notes to editors

 

Derwent London

 

Derwent London plc owns a portfolio of commercial real estate predominantly in central London valued at £3.1bn as at 30 June 2013, making us the largest London-focused real estate investment trust (REIT).

Our experienced team has a proven record of value creation through development, refurbishment and asset management activities. We take a fresh approach to each building, adopting a design-led and tenant-led philosophy. We focus on buildings with reversionary mid-market rents, particularly those in improving locations around the West End and the City borders.

The business is grounded on a strong balance sheet with modest leverage, a robust income stream and flexible financing.

Landmark schemes in our portfolio of 5.5 million sq ft (510,600m2) as at 30 June 2013 include Angel Building EC1, The Buckley Building EC1, Qube W1, Horseferry House SW1 and Tea Building E1.

In 2013 to date Derwent London has won the 'West End Deal of the Year' for our letting to Burberry at 1 Page Street SW1 and 'City Development of the Year' for our 4 & 10 Pentonville Road N1 scheme at the OAS Development Awards as well as 'Developer of the Year' at the New Energy & Cleantech Awards. In addition the 2012 Report & Accounts and 2012 Sustainability Report have been awarded an EPRA Gold award

Derwent London came seventh overall in the 2012 Management Today awards for 'Britain's Most Admired Companies', topping the real estate sector for the third year in a row. Earlier in 2012 the Group won the Estates Gazette 'Property Company of the Year - Offices' award. Last year the Tea Building also won a RIBA regional award and an AJ Retrofit award for the 'Green Tea' refurbishment to improve the environmental performance of the building.

For further information see www.derwentlondon.com or follow us on Twitter at @derwentlondon.

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCEAPEFESKDFEF
Date   Source Headline
1st Jul 20145:45 pmRNSTotal Voting Rights
11th Jun 201410:30 amRNSAdditional Listing
3rd Jun 20144:00 pmRNSDirector/PDMR Shareholding
3rd Jun 20144:00 pmRNSDirector/PDMR Shareholding
3rd Jun 20144:00 pmRNSDirector/PDMR Shareholding
3rd Jun 20144:00 pmRNSDirector/PDMR Shareholding
3rd Jun 20144:00 pmRNSDirector/PDMR Shareholding
3rd Jun 20144:00 pmRNSDirector/PDMR Shareholding
2nd Jun 20145:25 pmRNSTotal Voting Rights
30th May 20144:10 pmRNSResolutions of the 2014 Annual General Meeting
21st May 201411:00 amRNSBlocklisting Interim Review
16th May 20145:15 pmRNSResult of AGM
16th May 20143:00 pmRNSBondholders meeting
14th May 20144:55 pmRNSScrip Dividend Scheme
14th May 201412:30 pmRNSHolding(s) in Company
8th May 20147:00 amRNSInterim Management Statement
1st May 20144:00 pmRNSTotal Voting Rights
17th Apr 20149:00 amRNSDocuments available at NSM
14th Apr 20144:30 pmRNSDirector/PDMR Shareholding
14th Apr 20144:30 pmRNSDirector/PDMR Shareholding
14th Apr 20144:30 pmRNSDirector/PDMR Shareholding
14th Apr 20144:30 pmRNSDirector/PDMR Shareholding
14th Apr 20144:30 pmRNSDirector/PDMR Shareholding
14th Apr 20144:30 pmRNSDirector/PDMR Shareholding
4th Apr 20144:24 pmRNSDirector/PDMR Shareholding
4th Apr 20144:23 pmRNSDirector/PDMR Shareholding
4th Apr 20144:20 pmRNSDirector/PDMR Shareholding
4th Apr 20144:20 pmRNSDirector/PDMR Shareholding
4th Apr 20144:20 pmRNSDirector/PDMR Shareholding
4th Apr 20144:20 pmRNSDirector/PDMR Shareholding
2nd Apr 20149:29 amRNSTotal Voting Rights
28th Mar 201410:30 amRNSBlocklisting Interim Review
24th Mar 20147:00 amRNSSale of Jaeger House, 57 Broadwick Street W1
20th Mar 20142:00 pmRNSChange of auditor
19th Mar 20143:55 pmRNSHolding(s) in Company
17th Mar 201410:00 amRNSAdditional Listing
13th Mar 201410:00 amRNSHolding(s) in Company
27th Feb 20147:00 amRNSFinal Results
22nd Jan 20143:00 pmRNSHolding(s) in Company
22nd Jan 20141:15 pmRNSNotice of Results
9th Jan 20149:00 amRNSCompletion of £100m Private Placement
8th Jan 20142:45 pmRNSDirectorate Change
7th Jan 20149:00 amRNSDerwent London acquisition of 22 Kingsway WC2
20th Dec 20133:40 pmRNSHolding(s) in Company
16th Dec 20133:09 pmRNSHolding(s) in Company
6th Dec 20133:00 pmRNSHolding(s) in Company
27th Nov 20135:55 pmRNSHolding(s) in Company
21st Nov 201311:00 amRNSBlocklisting Interim Review
13th Nov 20137:00 amRNSQ3 Interim Management Statement
4th Nov 201312:30 pmRNSNotice of Interim Management Statement

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.